Zimmer Operating Cycle from 2010 to 2026

ZBH Stock  USD 85.71  0.28  0.33%   
Zimmer Biomet's Operating Cycle is increasing with slightly volatile movements from year to year. Operating Cycle is predicted to flatten to 321.12. For the period between 2010 and 2026, Zimmer Biomet, Operating Cycle quarterly trend regression had mean deviation of  54.41 and range of 297. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
398.46
Current Value
321.12
Quarterly Volatility
73.45609689
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Zimmer Biomet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zimmer Biomet's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 B, Interest Expense of 145.4 M or Selling General Administrative of 2.1 B, as well as many indicators such as Price To Sales Ratio of 4.48, Dividend Yield of 0.0153 or PTB Ratio of 1.88. Zimmer financial statements analysis is a perfect complement when working with Zimmer Biomet Valuation or Volatility modules.
  
Build AI portfolio with Zimmer Stock
Check out the analysis of Zimmer Biomet Correlation against competitors.

Latest Zimmer Biomet's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Zimmer Biomet Holdings over the last few years. It is Zimmer Biomet's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zimmer Biomet's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Zimmer Operating Cycle Regression Statistics

Arithmetic Mean424.55
Geometric Mean418.47
Coefficient Of Variation17.30
Mean Deviation54.41
Median421.23
Standard Deviation73.46
Sample Variance5,396
Range297
R-Value0.29
Mean Square Error5,268
R-Squared0.08
Significance0.26
Slope4.23
Total Sum of Squares86,333

Zimmer Operating Cycle History

2026 321.12
2025 398.46
2024 442.73
2023 488.99
2022 460.74
2021 467.27
2020 576.86

About Zimmer Biomet Financial Statements

Investors use fundamental indicators, such as Zimmer Biomet's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Zimmer Biomet's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Operating Cycle 398.46  321.12 

Currently Active Assets on Macroaxis

When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
Check out the analysis of Zimmer Biomet Correlation against competitors.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is there potential for Health Care Equipment & Supplies market expansion? Will Zimmer introduce new products? Factors like these will boost the valuation of Zimmer Biomet. Anticipated expansion of Zimmer directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Dividend Share
0.96
Earnings Share
4.03
Revenue Per Share
40.352
Quarterly Revenue Growth
0.097
Zimmer Biomet Holdings's market price often diverges from its book value, the accounting figure shown on Zimmer's balance sheet. Smart investors calculate Zimmer Biomet's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Zimmer Biomet's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.